Physician profile
Irram Hamdani
NPI 1245433952
$1,842.90
in general payments reported to CMS, 2019-2025
27 companies · $317 in 2025
The $317 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $257 · 2020: $605 · 2021: $242 · 2022: $108 · 2023: $129 · 2024: $184 · 2025: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $631.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $631.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $410.12 | 2020-2021 | |
| Actelion Pharmaceuticals US, INC. | $205.23 | 2020-2024 | Opsumit, Uptravi |
| Cvrx, INC. | $194.33 | 2022-2025 | Barostim Neo System |
| Inspire Medical Systems, INC. | $153.98 | 2021-2024 | Inspire |
| Glaxosmithkline, LLC. | $104.74 | 2019-2025 | Nucala |
| Endologix LLC | $89.99 | 2019 | |
| Insmed, INC. | $85.51 | 2024-2025 | Arikayce |
| Philips North America LLC | $84.39 | 2019-2023 | |
| United Therapeutics Corporation | $48.07 | 2022 | |
| Grifols USA, LLC | $47.17 | 2020 | |
| 3b Medical, INC. | $46.87 | 2025 | Luna |
| Globus Medical, INC. | $45.30 | 2025 | Senza |
| Pulmonx Corporation | $40.80 | 2025 | Chartis Catheter, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.33 | 2020-2025 | |
| Vifor Pharma, INC. | $29.89 | 2024 | Zemaira |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $29.72 | 2022 | |
| Harmony Biosciences LLC | $28.65 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $20.47 | 2019 | |
| Axsome Therapeutics, INC. | $19.23 | 2024 | Sunosi |
| Boston Scientific Corporation | $19.12 | 2019 | |
| Gilead Sciences, INC. | $18.53 | 2021 | |
| Olympus America INC. | $16.18 | 2020 | |
| Inogen, INC. | $16.08 | 2023 | Inogen |
| Kestra Medical Technology Services, INC. | $14.95 | 2025 | Assure Wcd |
| Sunovion Pharmaceuticals INC. | $13.87 | 2019 | |
| Medtronic, INC. | $13.60 | 2025 | Turbohawk |
| Veran Medical Technologies, INC. | $10.78 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irram Hamdani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.